Verition Fund Management’s NuVasive, Inc. NUVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-102,814
| Closed | -$4.28M | – | 2797 |
|
|
2023
Q2 | $4.28M | Buy |
102,814
+92,104
| +860% | +$3.78M | 0.06% | 408 |
|
|
2023
Q1 | $442K | Buy |
+10,710
| New | +$458K | 0.01% | 1307 |
|
|
2022
Q4 | – | Sell |
-24,391
| Closed | -$1.07M | – | 2997 |
|
|
2022
Q3 | $1.07M | Buy |
24,391
+14,084
| +137% | +$683K | 0.01% | 1350 |
|
|
2022
Q2 | $507K | Buy |
+10,307
| New | +$553K | 0.01% | 1447 |
|
|
2022
Q1 | – | Sell |
-39,932
| Closed | -$2.1M | – | 3150 |
|
|
2021
Q4 | $2.1M | Buy |
+39,932
| New | +$2.17M | 0.02% | 856 |
|
|
2021
Q3 | – | Sell |
-3,045
| Closed | -$206K | – | 2423 |
|
|
2021
Q2 | $206K | Buy |
+3,045
| New | +$208K | ﹤0.01% | 1566 |
|
|
2019
Q1 | – | Sell |
-5,051
| Closed | -$250K | – | 1362 |
|
|
2018
Q4 | $250K | Buy |
+5,051
| New | +$304K | 0.02% | 682 |
|
|
2018
Q2 | – | Sell |
-24,302
| Closed | -$1.27M | – | 1398 |
|
|
2018
Q1 | $1.27M | Buy |
+24,302
| New | +$1.23M | 0.09% | 280 |
|
|
2017
Q3 | – | Sell |
-3,031
| Closed | -$233K | – | 1433 |
|
|
2017
Q2 | $233K | Buy |
+3,031
| New | +$227K | 0.02% | 777 |
|
|
2016
Q3 | – | Sell |
-3,554
| Closed | -$212K | – | 1347 |
|
|
2016
Q2 | $212K | Buy |
+3,554
| New | +$192K | 0.03% | 749 |
|
Other funds holding NUVA
Verition Fund Management's NUVA Position: Q3 2023 in Review
Verition Fund Management sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 102,814 shares — an estimated $4.28M sold.
Verition Fund Management first reported a position in NUVA in Q2 2016 and held it in 10 quarters. The position peaked at $4.28M in Q2 2023. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.
- Verition Fund Management reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
- Verition Fund Management sold 102,814 NuVasive, Inc. shares in Q3 2023, an estimated $4.28M.
- Verition Fund Management first reported a position in NuVasive, Inc. in Q2 2016 and held it in 10 quarters.
- Verition Fund Management's NuVasive, Inc. position peaked at $4.28M in Q2 2023.
- 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.
Based on Verition Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.